Tolcapone and fulminant hepatitis
Published inLancet, vol. 352, no. 9132, 958
Publication date1998
Keywords
- Aged
- Antiparkinson Agents/adverse effects
- Benzophenones/adverse effects
- Drug-Induced Liver Injury/etiology
- Female
- Humans
- Liver Failure, Acute/chemically induced
- Nitrophenols
- Parkinson Disease/drug therapy
Citation (ISO format)
ASSAL, Frédéric et al. Tolcapone and fulminant hepatitis. In: Lancet, 1998, vol. 352, n° 9132, p. 958. doi: 10.1016/S0140-6736(05)61511-5
Main files (1)
Article (Published version)
Identifiers
- PID : unige:54892
- DOI : 10.1016/S0140-6736(05)61511-5
- PMID : 9752821
ISSN of the journal0140-6736
